Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Suda Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Neurotech fires a strategic adviser after claims he’s a dud, shares fall 17pc
Health & Biotech
Pot stock Zelda is coming to America – someday – after signing a pharma deal
Health & Biotech
Weed week: In Canada pot is hot; in Australia it’s just a steady glow
Health & Biotech
This health small cap has grown by more than 8000pc in the last decade
News
Lunchtime ASX small cap wrap: who’s laughing all the way to the bank today
Health & Biotech
Suda signs deal with $936bn pharma company to sell its insomnia spray
Health & Biotech
Zelda and viagra mouth spray maker Suda team up to do pot
Health & Biotech
Check up: here’s what’s happening with 140 ASX small cap health stocks
News
Lunchtime ASX small cap wrap: who’s going for a hole-in-one
Health & Biotech
Suda strikes a deal to develop migraine drug in US; shares jump 80pc
Health & Biotech
Weed week: here’s all the news driving ASX cannabis stocks
Health & Biotech
Suda blames Biotron comparisons on Twitter for 60pc share price spike
Health & Biotech
Rhinomed does US deal to put cannabis up your nose
News
Lunchtime ASX small cap wrap: who’s storming ahead today
Health & Biotech
Medlab’s cannabis mouth spray for cancer pain is a step closer after test results
Health & Biotech
Undervalued Suda due for a rise with Viagra spray
Health & Biotech
